Differential targeting of Gbetagamma-subunit signaling with small molecules.

Science
Tabetha M BonacciAlan V Smrcka

Abstract

G protein betagamma subunits have potential as a target for therapeutic treatment of a number of diseases. We performed virtual docking of a small-molecule library to a site on Gbetagamma subunits that mediates protein interactions. We hypothesized that differential targeting of this surface could allow for selective modulation of Gbetagamma subunit functions. Several compounds bound to Gbetagamma subunits with affinities from 0.1 to 60 muM and selectively modulated functional Gbetagamma-protein-protein interactions in vitro, chemotactic peptide signaling pathways in HL-60 leukocytes, and opioid receptor-dependent analgesia in vivo. These data demonstrate an approach for modulation of G protein-coupled receptor signaling that may represent an important therapeutic strategy.

References

Jan 25, 1996·Nature·D G LambrightP B Sigler
Aug 23, 1996·Journal of Molecular Biology·M RareyG Klebe
Jan 1, 1997·Annual Review of Pharmacology and Toxicology·D E Clapham, E J Neer
Feb 7, 1998·Proceedings of the National Academy of Sciences of the United States of America·E R Neptune, H R Bourne
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·G IaccarinoW J Koch
Jul 16, 1999·Clinical and Experimental Pharmacology & Physiology·M Connor, M D Christie
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·W XieD Wu
Dec 12, 2001·Current Opinion in Chemical Biology·A G Cochran
Feb 23, 2002·Journal of Molecular Graphics & Modelling·Robert D ClarkJames B Matthew
Dec 13, 2003·Endocrine Reviews·Theresa M Cabrera-VeraHeidi E Hamm
Jan 22, 2004·Science's STKE : Signal Transduction Knowledge Environment·Yehia Daaka
Apr 3, 2004·Nature Reviews. Drug Discovery·Michelle R Arkin, James A Wells
Apr 20, 2004·Assay and Drug Development Technologies·Guido Iaccarino, Walter J Koch
May 20, 2005·Nature·Tilman OltersdorfSaul H Rosenberg

❮ Previous
Next ❯

Citations

Mar 28, 2012·Cellular and Molecular Neurobiology·Laura M Harrison
Apr 6, 2013·Trends in Pharmacological Sciences·Alan V Smrcka
Dec 16, 2006·ACS Chemical Biology·William W JaRichard W Roberts
May 13, 2009·Journal of Chemical Information and Modeling·Min-Sun ParkHarry A Stern
Sep 19, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Levi L Blazer, Richard R Neubig
Dec 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Gonzalo E YevenesLuis G Aguayo
Feb 13, 2009·Proceedings of the National Academy of Sciences of the United States of America·Mikel Garcia-MarcosMarilyn G Farquhar
Dec 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Alan V SmrckaErnest Giralt
Jun 27, 2012·Proceedings of the National Academy of Sciences of the United States of America·Xiaofeng LiDianqing Wu
Aug 4, 2009·The Journal of Biological Chemistry·Mohammed Akli AyoubGrégoire Pierre Prévost
Feb 26, 2011·The Journal of Biological Chemistry·Xiaoyun TangSonghai Chen
Dec 17, 2008·The Journal of Biological Chemistry·Nobuchika SuzukiTohru Kozasa
Sep 24, 2009·The Journal of Pharmacology and Experimental Therapeutics·Leonardo GuzmanLuis G Aguayo
Jan 30, 2010·The Journal of Pharmacology and Experimental Therapeutics·Joseph K KiruiYaping Tu
Oct 1, 2010·Molecular Pharmacology·Axel L DessalAlan V Smrcka
Oct 7, 2008·Annual Review of Pharmacology and Toxicology·Denis J DupréTerence E Hébert
Sep 18, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·William F SchwindingerJanet D Robishaw
Jun 26, 2010·Circulation Research·Liam M CaseyBurns C Blaxall
Jul 23, 2011·Circulation Research·Stephen L Belmonte, Burns C Blaxall
Apr 22, 2010·The Journal of Clinical Investigation·Stephen M MassaFrank M Longo
May 18, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Derek H RosenzweigVladlen Z Slepak
Nov 21, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jennifer L MathewsJean M Bidlack
Jan 7, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kirill UkhanovBarry W Ache
Jan 30, 2014·Science Signaling·Arun K Shukla
May 29, 2012·Nature Chemical Biology·Stefanie BlättermannEvi Kostenis
Jul 20, 2012·Nature Chemical Biology·Sébastien Granier, Brian Kobilka
Apr 1, 2008·Expert Opinion on Drug Discovery·Annette Gilchrist
Feb 1, 2007·Expert Opinion on Drug Discovery·Paul A Whittaker
Sep 4, 2015·The American Journal of the Medical Sciences·Rohan SamsonThierry H Le Jemtel
Feb 16, 2013·Trends in Pharmacological Sciences·Hashem A Dbouk, Jonathan M Backer
Jan 25, 2011·Journal of Molecular and Cellular Cardiology·Fadia A KamalBurns C Blaxall
Jan 25, 2011·Pharmacology & Therapeutics·Richard Eglen, Terry Reisine
Dec 18, 2010·Neuroscience Letters·Franklin A LeeLaura M Harrison
Jun 9, 2009·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Motohiko Sato, Yoshihiro Ishikawa
Apr 22, 2006·Science·John Joseph Grubb Tesmer
Sep 4, 2015·Cellular Signalling·Thamara Hewavitharana, Philip B Wedegaertner
Dec 2, 2014·Structure·Angeline M LyonJohn J G Tesmer

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.